“Suswasthya”
- A Systemic Care Division
Deurali – Janta with a view to expand its product profile
as per the increasing product demand of the market (and as per the
Essential Drugs List of Nepalese National Formulatory) have introduced
‘Suwasthya Division’ as an expansion to its current
range of products. more ...
DJPL - Search
Search the DJPL contents
Production
The manufacturing plant
at Kathmandu has seen strategic and significant
changes in the recent years to produce highest
quality products. The production processes have
been adopted and validated not only to meet with
WHO GMP guidelines but also to meet the requirement
of other international regulatory agencies. The
highly sophisticated state-of-the-art manufacturing
plant at Dhapasi, Kathmandu is operational to
produce highest quality products to meet the demanding
market of the present day.
Deurali-Janta currently
manufactures antibiotics & oral solids (Tables/Capsules/Dry
powders) as well as liquid dosage forms, in it’s
about 45,000 sq. ft. of Centrally Air Conditioned
facilities.
